Systemic Lupus Erythematosus Severity Transitions and Related Impact on Health‐Care Utilization and Costs
International Journal of Rheumatic Diseases · 2025
DOI: 10.1111/1756-185x.70500 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Yu-Sheng Chang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Ta…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Health Care Costs, Patient Acceptance of Health Care. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Aim
This study investigated the distribution of disease severity in patients with systemic lupus erythematosus (SLE), explored its impact on health‐care resource utilization and costs, and evaluated SLE severity transitions over time.
Methods
SLE patients between 2015 and 2017 in Taiwan's National Health Insurance Research Database were retrospectively analyzed, and classified into the mild, moderate, or severe SLE groups. Annual health‐care resource utilization, associated costs, lupus flare events, and severity transitions were analyzed.
Results
A total of 20 181 patients with SLE were included, 29.3% of whom had mild, 60.7% had moderate, and 9.9% had severe SLE. Severity was correlated with health‐care utilization and related costs, as well as the frequency and severity of flares. Patients with severe and moderate SLE incurred 2.18 and 1.42 times greater annual medical costs than those with mild SLE, respectively. Over the 2‐year follow‐up, the severe group experienced 13.23 flares, including 1.2 severe flares, significantly higher than those experienced by the moderate (9.38 flares, 0.34 severe flares) and mild (3.61 flares, 0.04 severe flares) SLE groups. Despite consistent severity distribution over 2 years, severity transitions occurred. Approximately 60% of severe patients improved within 1 year, 13% becoming mild. Conversely, fewer mild (2.8%–3.4%) and moderate (4.5%–5.4%) patients progressed to severe status annually.
Conclusion
This study offers insights into the distribution and transition patterns of SLE severity, and the correlation with health‐care utilization, costs, and flare severity/frequency within a nationwide cohort. These findings highlight the importance of targeted interventions for controlling disease severity in SLE management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
- Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Business Administration, Ling-Tung University, Taichung, Taiwan.
- College of Medicine National Chung Hsing University, Taichung, Taiwan.
ORCID-Profile: Yu-Sheng Chang, Jui-Hung Kao, Wen-Nan Huang
Zitieren
APA
Chang, Y. S., Kao, J. H., & Huang, W. N. (2025). Systemic Lupus Erythematosus Severity Transitions and Related Impact on Health‐Care Utilization and Costs. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70500
Vancouver
Chang YS, Kao JH, Huang WN. Systemic Lupus Erythematosus Severity Transitions and Related Impact on Health‐Care Utilization and Costs. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70500
BibTeX
@article{Chang2025,
author = {Chang, Yu-Sheng and Kao, Jui-Hung and Huang, Wen-Nan},
title = {Systemic Lupus Erythematosus Severity Transitions and Related Impact on Health‐Care Utilization and Costs},
journal = {International Journal of Rheumatic Diseases},
year = {2025},
doi = {10.1111/1756-185x.70500}
}
EUVIMED